New Age Ventures

Goodhood operates a subscription-based auto repair platform that provides convenient car maintenance services directly to customers' doorsteps. By connecting car owners with skilled mechanics, Goodhood allows users to browse, book, and manage their service appointments through an easy-to-use platform. This innovative approach enables customers to access highly-rated mobile car repair services at their convenience, making car maintenance more accessible and efficient.

Koios Medical, Inc. is a Chicago-based company that develops an ultrasound image analysis platform aimed at enhancing early disease detection and diagnosis. Founded in 2011, the company utilizes artificial intelligence and machine learning to create algorithms that serve as a decision support system. This platform is trained on extensive datasets, including hundreds of thousands of images and associated pathology results, enabling healthcare institutions to improve the accuracy of cancer detection and diagnosis. Koios Medical's focus is on delivering software medical device products that comply with customer and regulatory standards, ultimately enhancing clinical decision-making and the overall quality of care in the healthcare sector.

Goodhood operates a subscription-based auto repair platform that provides convenient car maintenance services directly to customers' doorsteps. By connecting car owners with skilled mechanics, Goodhood allows users to browse, book, and manage their service appointments through an easy-to-use platform. This innovative approach enables customers to access highly-rated mobile car repair services at their convenience, making car maintenance more accessible and efficient.

Tabella is a developer of a social networking software application tailored for Catholic communities, providing a free, private, and secure platform for users to engage digitally. The application facilitates communication among faith communities, allowing members to stay connected and deepen their religious practices. It offers subscription content that supports spiritual growth and enables churches to collect donations, fostering enhanced community engagement. Through its platform, Tabella aims to strengthen the bonds between individuals and their faith, promoting a sense of closeness to both their community and God.

Telescope Innovations is a chemical manufacturing company that operates as a Contract Research Organization (CRO). It specializes in providing contract research services and developing automation products. The company generates revenue through two main streams: offering contract research services and selling its automation products. In addition to these services, Telescope Innovations is also involved in intellectual property development and licensing, positioning itself as a versatile entity within the technology and chemical sectors.

FEMSelect is making a lasting impact on women's health by delivering an innovative technology platform. It is the developer of EnPlace, a minimally invasive and mesh-free system for pelvic floor ligament fixation. Using EnPlace takes approximately 30 minutes. The patented delivery system enables the precise guidance, insertion, and deployment of the anchor unit. The anchor is designed to be introduced through the vaginal wall and secured to the pelvic floor ligament to provide stabilization. FEMSelect was founded in 2012 and is headquartered in Modi’in, Israel.

Spruce Services, Inc. operates an online platform that connects users with service professionals for various household needs, including housekeeping, pet care, laundry, and dry cleaning. The platform allows users to customize services such as whole home cleaning, pet sitting, and laundry wash and fold, among others. Users can book verified professionals for tasks like tidying up, dog walking, and managing daily chores, ensuring a convenient and efficient service experience. Founded in 2016 and headquartered in Austin, Texas, the company was formerly known as Apartment Butler, Inc. before rebranding in June 2019. Spruce aims to change the way individuals access home services through its mobile app, catering primarily to residents in apartment complexes.

NewIV Medical is a developer of an IV infusion pump product designed to provide IV therapy to improve the cost of care.

Aqualung provides compact carbon capture systems for industrial flue gas and biogas, as well as membrane carbon capture and separation technology, to accelerate decarbonization and reduce carbon emission costs. This will remove a significant amount of CO2 that would otherwise be difficult to abate.

Spruce Services, Inc. operates an online platform that connects users with service professionals for various household needs, including housekeeping, pet care, laundry, and dry cleaning. The platform allows users to customize services such as whole home cleaning, pet sitting, and laundry wash and fold, among others. Users can book verified professionals for tasks like tidying up, dog walking, and managing daily chores, ensuring a convenient and efficient service experience. Founded in 2016 and headquartered in Austin, Texas, the company was formerly known as Apartment Butler, Inc. before rebranding in June 2019. Spruce aims to change the way individuals access home services through its mobile app, catering primarily to residents in apartment complexes.

Founded in 2012, Tilting Point has grown to a staff of over 130 people in offices in New York, Boston, Barcelona, Kiev and Seoul. Our partnerships with development studios and publishers extend our reach to over a dozen countries. Our most successful games include Star Trek Timelines, Warhammer: Chaos & Conquest, and SpongeBob: Krusty Cook-Off. The last one achieved top 10 standing in 97 different countries when it launched, and is still enjoyed by millions of players, along with our extended catalogue of games. To achieve success, Tilting Point employs a data-driven approach to game development and user acquisition, while powering up existing live games for independent developers who may become closer partners on a new joint project as our relationship grows. Interested in working with us? Reach out by emailing hello@tiltingpoint.com Interested in working for us? Check our job listings at www.tiltingpoint.com/careers Want to learn more about us? www.tiltingpoint.com Facebook: facebook.com/tiltingpoint Twitter: twitter.com/TiltingPoint

Li-FT Power is a cutting-edge company that focuses on identifying, exploring, discovering, and advancing early-stage lithium pegmatite projects in Canada. The company currently holds an interest in the Rupert Project, which is a 155,000-hectare greenfield lithium pegmatite exploration project.

Artract Medical hemodynamic assist device for the treatment of the heart. The Attract System is a passive hemodynamic assist device that is implanted percutaneously for the treatment of heart failure with preserved ejection fraction. Artract reduces left atrial blood pressure, easing shortness of breath.

MetaSoul, based in New York and established in 2017, specializes in advanced emotion synthesis technology for artificial intelligence applications. The company focuses on creating emotional awareness in AI, enabling machines to generate and understand a range of emotional states through multimodal stimuli. MetaSoul's flagship product, the Emotional Processing Unit (EPU), allows AI systems to respond to user interactions with emotional intelligence, enhancing applications in diverse fields such as gaming, healthcare, and the metaverse. The technology is capable of controlling both vocal expressions and facial micro-expressions in digital entities, providing a more lifelike interaction experience. MetaSoul holds foundational patents for its innovative approach to emotion synthesis, which not only detects but also shapes emotional responses in machines. By utilizing reinforcement learning and a unique Emotion Profile Graph, the technology allows for the development of distinct emotional personalities in AI, creating a personalized user experience. As generative AI continues to evolve, MetaSoul positions itself as a leader in integrating emotional intelligence into digital interactions, paving the way for more meaningful engagements between humans and machines.

Tabella is a developer of a social networking software application tailored for Catholic communities, providing a free, private, and secure platform for users to engage digitally. The application facilitates communication among faith communities, allowing members to stay connected and deepen their religious practices. It offers subscription content that supports spiritual growth and enables churches to collect donations, fostering enhanced community engagement. Through its platform, Tabella aims to strengthen the bonds between individuals and their faith, promoting a sense of closeness to both their community and God.

BrainCheck, Inc. specializes in cognitive health solutions for healthcare and athletic organizations in the United States, focusing on assessment and monitoring of cognitive health. The company offers a mobile application compatible with iOS and Android devices that provides tools for individuals to evaluate their cognitive health, particularly concerning issues like concussions and memory changes. This application facilitates the connection between patients and care teams in the concussion and dementia sectors. Users can access interactive tests and screening tools via any mobile device or web browser, allowing for immediate assessment of brain health. Clinicians can track significant changes in cognitive health and share results with patients, thereby enhancing decision-making regarding cognitive health concerns. Founded in 2013, BrainCheck is headquartered in Houston, Texas.

MetaSoul, based in New York and established in 2017, specializes in advanced emotion synthesis technology for artificial intelligence applications. The company focuses on creating emotional awareness in AI, enabling machines to generate and understand a range of emotional states through multimodal stimuli. MetaSoul's flagship product, the Emotional Processing Unit (EPU), allows AI systems to respond to user interactions with emotional intelligence, enhancing applications in diverse fields such as gaming, healthcare, and the metaverse. The technology is capable of controlling both vocal expressions and facial micro-expressions in digital entities, providing a more lifelike interaction experience. MetaSoul holds foundational patents for its innovative approach to emotion synthesis, which not only detects but also shapes emotional responses in machines. By utilizing reinforcement learning and a unique Emotion Profile Graph, the technology allows for the development of distinct emotional personalities in AI, creating a personalized user experience. As generative AI continues to evolve, MetaSoul positions itself as a leader in integrating emotional intelligence into digital interactions, paving the way for more meaningful engagements between humans and machines.

The Arcview Group, LLC is an investment and research company focused on the legal cannabis industry, established in 2009 and headquartered in San Francisco, California. It connects investors with cannabis-related businesses and projects, facilitating financing through its network of members. The company supports a diverse range of cannabis sectors, including cultivation, retail, infused product manufacturing, and ancillary services such as LED lighting, compliance technology, and security solutions. Additionally, the Arcview Group offers resources like webinars and the Arcview Angel Network to help entrepreneurs raise capital and grow their businesses. Through its investment arm, the Arcview Collective Fund, the organization targets early-stage opportunities, making investments ranging from $50,000 to $250,000, leveraging the expertise of its members to cultivate innovation within the industry.

Venock Inc. is a MedTech startup based in New York City with operations in Munich, Germany, focused on developing innovative vascular closure devices for large bore access sites exceeding 8 mm, primarily in venous applications. Established in 2018, the company addresses a significant unmet need in the industry, targeting a market valued over $2 billion. Venock's device significantly improves closure time, achieving full vascular closure within one minute compared to traditional manual compression methods, which are time-consuming and uncomfortable for patients. The handheld, fully percutaneous system enhances efficiency for healthcare professionals by enabling rapid cessation of venous bleeding, thereby reducing hospital resource drain and improving patient turnover during interventional transcatheter therapies. While currently focused on venous closure, the underlying technology is applicable to both veins and arteries.

Neosensory focus on sending a variety of data streams to the brain via the sense of touch. With so much unused real estate on the body, the skin presents huge potential for the delivery of new information. They are currently building the world’s first hearing assistive technology that enables people to listen with their skin.

MetaSoul, based in New York and established in 2017, specializes in advanced emotion synthesis technology for artificial intelligence applications. The company focuses on creating emotional awareness in AI, enabling machines to generate and understand a range of emotional states through multimodal stimuli. MetaSoul's flagship product, the Emotional Processing Unit (EPU), allows AI systems to respond to user interactions with emotional intelligence, enhancing applications in diverse fields such as gaming, healthcare, and the metaverse. The technology is capable of controlling both vocal expressions and facial micro-expressions in digital entities, providing a more lifelike interaction experience. MetaSoul holds foundational patents for its innovative approach to emotion synthesis, which not only detects but also shapes emotional responses in machines. By utilizing reinforcement learning and a unique Emotion Profile Graph, the technology allows for the development of distinct emotional personalities in AI, creating a personalized user experience. As generative AI continues to evolve, MetaSoul positions itself as a leader in integrating emotional intelligence into digital interactions, paving the way for more meaningful engagements between humans and machines.

High North Laboratories is a cannabis-specific company focused on providing quality testing and GMP compliance for the cannabis industry. Built on a digital infrastructure, the laboratory aims to deliver faster and more reliable results to cannabis growers and producers. By ensuring transparency in product testing, High North Laboratories helps customers access quality cannabis products, thereby setting a standard for testing within the sector.

Annex specializes in the design and manufacture of innovative smoking instruments that aim to minimize the smoke and odor associated with smoking. The company has developed a comprehensive smoking kit equipped with features such as a long-lasting battery, an auto extinguishing system, and a removable mouthpiece for sanitation purposes. Additionally, the kit incorporates a filter track system made from eco-friendly plastics derived from cannabis waste. This product is intended to address the adverse effects of secondhand smoke, offering a more considerate experience for cannabis smokers and those in their vicinity.

MetaSoul, based in New York and established in 2017, specializes in advanced emotion synthesis technology for artificial intelligence applications. The company focuses on creating emotional awareness in AI, enabling machines to generate and understand a range of emotional states through multimodal stimuli. MetaSoul's flagship product, the Emotional Processing Unit (EPU), allows AI systems to respond to user interactions with emotional intelligence, enhancing applications in diverse fields such as gaming, healthcare, and the metaverse. The technology is capable of controlling both vocal expressions and facial micro-expressions in digital entities, providing a more lifelike interaction experience. MetaSoul holds foundational patents for its innovative approach to emotion synthesis, which not only detects but also shapes emotional responses in machines. By utilizing reinforcement learning and a unique Emotion Profile Graph, the technology allows for the development of distinct emotional personalities in AI, creating a personalized user experience. As generative AI continues to evolve, MetaSoul positions itself as a leader in integrating emotional intelligence into digital interactions, paving the way for more meaningful engagements between humans and machines.

OrthogenRx is a commercial-stage product development company focused on orthopedic medical devices aimed at treating musculoskeletal conditions, particularly knee joint pain. The company's primary product is an injection designed to lubricate the knee joint and alleviate mild to moderate pain for patients who have not adequately responded to conservative treatments. OrthogenRx employs a business model that leverages exclusive supply and license agreements for products available outside the United States, while also pursuing generic product approval domestically. This approach aims to reduce healthcare costs significantly by utilizing existing regulations for abbreviated approval of generic devices, similar to the process for generic drugs. By providing safe and effective non-surgical alternatives, OrthogenRx addresses the needs of patients seeking relief from joint pain.

OrthogenRx is a commercial-stage product development company focused on orthopedic medical devices aimed at treating musculoskeletal conditions, particularly knee joint pain. The company's primary product is an injection designed to lubricate the knee joint and alleviate mild to moderate pain for patients who have not adequately responded to conservative treatments. OrthogenRx employs a business model that leverages exclusive supply and license agreements for products available outside the United States, while also pursuing generic product approval domestically. This approach aims to reduce healthcare costs significantly by utilizing existing regulations for abbreviated approval of generic devices, similar to the process for generic drugs. By providing safe and effective non-surgical alternatives, OrthogenRx addresses the needs of patients seeking relief from joint pain.

OrthogenRx is a commercial-stage product development company focused on orthopedic medical devices aimed at treating musculoskeletal conditions, particularly knee joint pain. The company's primary product is an injection designed to lubricate the knee joint and alleviate mild to moderate pain for patients who have not adequately responded to conservative treatments. OrthogenRx employs a business model that leverages exclusive supply and license agreements for products available outside the United States, while also pursuing generic product approval domestically. This approach aims to reduce healthcare costs significantly by utilizing existing regulations for abbreviated approval of generic devices, similar to the process for generic drugs. By providing safe and effective non-surgical alternatives, OrthogenRx addresses the needs of patients seeking relief from joint pain.

BootstrapLabs is a venture capital firm founded in 2008 and based in South San Francisco, California, with additional offices in San Francisco and Redwood City. The firm specializes in seed and early-stage investments, focusing on sectors such as applied artificial intelligence, fintech, technology, software, cybersecurity, and logistics. It aims to support foreign-born startups from Asia and Europe, helping them navigate the Silicon Valley ecosystem and the American market. BootstrapLabs operates two accelerator programs: a Global Accelerator Program in Silicon Valley tailored for foreign entrepreneurs, and a Local Accelerator Program in Southeast Asia. Both programs provide funding and mentoring to early-stage companies, emphasizing the importance of strong teams and innovative technology. The firm typically invests up to $0.1 million in selected startups, which must have at least two team members capable of coding and building user experiences. BootstrapLabs seeks to act as a lead investor and co-invest in its portfolio companies, committing to nurturing the founders through the challenges of building successful businesses.

OrthogenRx is a commercial-stage product development company focused on orthopedic medical devices aimed at treating musculoskeletal conditions, particularly knee joint pain. The company's primary product is an injection designed to lubricate the knee joint and alleviate mild to moderate pain for patients who have not adequately responded to conservative treatments. OrthogenRx employs a business model that leverages exclusive supply and license agreements for products available outside the United States, while also pursuing generic product approval domestically. This approach aims to reduce healthcare costs significantly by utilizing existing regulations for abbreviated approval of generic devices, similar to the process for generic drugs. By providing safe and effective non-surgical alternatives, OrthogenRx addresses the needs of patients seeking relief from joint pain.

TRANSCATHETER TECHNOLOGIES is developing a unique aortic valve implantation system that will increase the safety and durability of aortic valve implantation. The TRINITY repositionable transcatheter aortic valve system is at the forefront of next-generation transcatheter valve implantation technology. In the near future, transcatheter valve implantation will become the preferred therapy for aortic valve implantation, and TRANSCATHETER TECHNOLOGIES‘ goal is to provide the most advanced technology available.

TRANSCATHETER TECHNOLOGIES is developing a unique aortic valve implantation system that will increase the safety and durability of aortic valve implantation. The TRINITY repositionable transcatheter aortic valve system is at the forefront of next-generation transcatheter valve implantation technology. In the near future, transcatheter valve implantation will become the preferred therapy for aortic valve implantation, and TRANSCATHETER TECHNOLOGIES‘ goal is to provide the most advanced technology available.